A model for the early-stage screening of colorectal cancer was created using seven consensus biomarkers (namely ESM1, DHRS7C, OTOP3, AADACL2, LPHN3, GABRD, and LPAR1), and yielded >98% balanced accuracy on external validation. This evidence concerns the gene ADGRL3 and colorectal cancer.